80 related articles for article (PubMed ID: 23475561)
1. Unexpected thrombocytopenia and anemia in cynomolgus monkeys induced by a therapeutic human monoclonal antibody.
Everds N; Li N; Bailey K; Fort M; Stevenson R; Jawando R; Salyers K; Jawa V; Narayanan P; Stevens E; He C; Nguyen MP; Tran S; Doyle N; Poitout-Belissent F; Jolette J; Xu C; Sprugel K
Toxicol Pathol; 2013; 41(7):951-69. PubMed ID: 23475561
[TBL] [Abstract][Full Text] [Related]
2. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody.
Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N
Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394
[TBL] [Abstract][Full Text] [Related]
3. Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin.
Rudmann DG; Page TJ; Vahle JL; Chouinard L; Haile S; Poitout F; Baskin G; Lambert AJ; Walker P; Glazier G; Awori M; Bernier L
Toxicol Sci; 2012 Feb; 125(2):586-94. PubMed ID: 22106037
[TBL] [Abstract][Full Text] [Related]
4. Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.
Zhang Y; Sun J; Tan M; Liu Y; Li Q; Jiang H; Wang H; Li Z; Wan W; Jiang H; Lu H; Wang B; Ren J; Gong L
Mol Ther; 2018 Jun; 26(6):1457-1470. PubMed ID: 29724685
[TBL] [Abstract][Full Text] [Related]
5. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Monocyte/Macrophage Phagocytosis Assay for the Prediction of Drug-Induced Thrombocytopenia.
Narayanan PK; Li N
Curr Protoc Toxicol; 2019 Feb; 79(1):e68. PubMed ID: 30673165
[TBL] [Abstract][Full Text] [Related]
7. Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro.
Liu L; Jacobsen FW; Everds N; Zhuang Y; Yu YB; Li N; Clark D; Nguyen MP; Fort M; Narayanan P; Kim K; Stevenson R; Narhi L; Gunasekaran K; Bussiere JL
J Biol Chem; 2017 Feb; 292(5):1876-1883. PubMed ID: 27994063
[TBL] [Abstract][Full Text] [Related]
8. Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey.
Oshima T; Miyashita H; Ishimura Y; Ito Y; Tanaka Y; Hori A; Kokubo T; Kurokawa T
PLoS One; 2018; 13(5):e0196422. PubMed ID: 29723247
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
10. Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and Monitoring.
Guffroy M; Falahatpisheh H; Biddle K; Kreeger J; Obert L; Walters K; Goldstein R; Boucher G; Coskran T; Reagan W; Sullivan D; Huang C; Sokolowski S; Giovanelli R; Gerber HP; Finkelstein M; Khan N
Clin Cancer Res; 2017 Apr; 23(7):1760-1770. PubMed ID: 27683177
[No Abstract] [Full Text] [Related]
11. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix.
Vugmeyster Y; Howell K; Bakshl A; Flores C; Canova-Davis E
Cytometry A; 2003 Apr; 52(2):101-9. PubMed ID: 12655653
[TBL] [Abstract][Full Text] [Related]
12. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
Miederer M; McDevitt MR; Sgouros G; Kramer K; Cheung NK; Scheinberg DA
J Nucl Med; 2004 Jan; 45(1):129-37. PubMed ID: 14734685
[TBL] [Abstract][Full Text] [Related]
14. Male and female fertility assessment in the cynomolgus monkey following administration of ABT-874, a human Anti-IL-12/23p40 monoclonal antibody.
Enright BP; Tornesi B; Weinbauer GF; Blaich G
Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):421-30. PubMed ID: 23213064
[TBL] [Abstract][Full Text] [Related]
15. Characterization, biomarkers, and reversibility of a monoclonal antibody-induced immune complex disease in cynomolgus monkeys (Macaca fascicularis).
Heyen JR; Rojko J; Evans M; Brown TP; Bobrowski WF; Vitsky A; Dalton S; Tripathi N; Bollini SS; Johnson T; Lin JC; Khan N; Han B
Toxicol Pathol; 2014 Jun; 42(4):765-73. PubMed ID: 24616262
[TBL] [Abstract][Full Text] [Related]
16. Antibody C region influences TGN1412-like functional activity in vitro.
Ball C; Fox B; Hufton S; Sharp G; Poole S; Stebbings R; Eastwood D; Findlay L; Parren PW; Thorpe R; Bristow A; Thorpe SJ
J Immunol; 2012 Dec; 189(12):5831-40. PubMed ID: 23150712
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin M antiplatelet autoantibodies from mice immunized with rat platelets induce thrombocytopenia and platelet function impairment.
Detalle L; Su D; van Rooijen N; Coutelier JP
Exp Biol Med (Maywood); 2010 Dec; 235(12):1464-71. PubMed ID: 21127343
[TBL] [Abstract][Full Text] [Related]
19. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody.
Enright BP; Tornesi B; Weinbauer GF; Blaich G
Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects.
Halpern WG; Lappin P; Zanardi T; Cai W; Corcoran M; Zhong J; Baker KP
Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
